ALT Run with your doctor. Saturday 24 June, 3pm, Raphael Park. Take the first steps in your road to fitness and join us for a 30-minute walk, jog, or run with some of our doctors - do it at your own pace! Unsure if you can take part? Speak to your doctor for medical advice. How to get here: Use the Parkway entrance, near the tennis courts. Postcode: RM2 5EB. By bus: route number 498 or 174.
ALT Images from the International Clinical Trials Day Stall at Queen's Hospital in Romford.
ALT Images from the International Clinical Trials Day Stall at Queen's Hospital in Romford.
ALT Images from the International Clinical Trials Day Stall at Queen's Hospital in Romford.
ALT Images from the International Clinical Trials Day Stall at Queen's Hospital in Romford.
ALT L-R: Sam, Janice, Darryl (PI), Naas and Lunik
ALT Baricitinib is an anti-inflammatory treatment licensed for use in moderate to severe rheumatoid arthritis and moderate to severe atopic dermatitis, and has been studied in patients who are hospitalised due to COVID-19. It is a selective and reversible Janus kinase (JAK) 1 and 2 inhibitor. JAK-inhibitors are thought to control high levels of cytokines and inflammation, seen in patients with severe SARS-CoV-2 infection (Walz et al 2020).
ALT "They say laughter is the best medicine, I say, there is no laughter if there is no cure. And there is no cure if there is no medicine!! We can only find these new medicines through clinical trials" Parveen Dugh, Senior Pharmacy Technician
ALT "Research gives hope to those who thought they may not see an outcome to their problem. Through clinical research, new outcomes are discovered that can not only change a patient’s treatment, but the way we continue to best treat all patients into the future." Victoria Darkins, Invoicing and Analytics Officer